School of Medicine and Health Management, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China.
School of Psychology and Public Health, La Trobe University, Melbourne, VIC, Australia.
Front Public Health. 2022 Oct 20;10:985188. doi: 10.3389/fpubh.2022.985188. eCollection 2022.
The public's irrational use of antibiotics for upper respiratory tract infections (URTIs) is prevalent worldwide. This study aims to synthesize evidence on how people use antibiotics to treat URTIs, its prevalence and determinants.
A mixed methods systematic review was conducted using a convergent segregated approach. Relevant studies were searched from PubMed, Cochrane Library, Embase, and Web of Science. A qualitative analysis was initiated, exploring the public's antibiotic use experience for URTIS based on the Consumer Behavior Model (CBM). This was followed by a quantitative synthesis, tapping into the prevalence and predictors of public behavior in antibiotic usage for URTIs. The segregated syntheses complemented each other and were further integrated.
A total of 86 studies were included: 48 quantitative, 30 qualitative, eight mixed methods studies. The included studies were conducted in Europe ( = 29), Asia ( = 27) and North America ( = 21), assessing the behaviors of patients ( = 46), their parents or caregivers ( = 31), or both ( = 9). Eleven themes emerged covering the six CBM stages: need recognition, information searching, alternative evaluation, antibiotic obtaining, antibiotic consumption, and post-consumption evaluation. The six stages reinforce each other, forming a vicious cycle. The high prevalence of the public's irrational use of antibiotics for URTIs is evident despite the high heterogeneity of the studies (ranging from 0.0 to 92.7%). The perceived seriousness of illness and misbelief in antibiotics were identified consistently across the studies as the major motivation driving the public's irrational use of antibiotics for URTIs. However, individual capacity (e.g., knowledge) and opportunity (e.g., contextual restriction) in reducing antibiotic use have mixed effect.
Systemic interventions concerning both supply and demand sides are warranted. The public needs to be educated about the appropriate management of URTIs and health care providers need to re-shape public attitudes toward antibiotic use for URTIs through communication and prescribing practices.
https://www.crd.york.ac.uk/prospero, identifier: CRD42021266407.
公众对抗生素治疗上呼吸道感染(URTIs)的不合理使用在全球范围内普遍存在。本研究旨在综合证据,了解人们如何使用抗生素治疗 URTIs、其流行程度和决定因素。
采用收敛分离方法进行混合方法系统评价。从 PubMed、Cochrane 图书馆、Embase 和 Web of Science 中检索相关研究。首先进行定性分析,根据消费者行为模型(CBM)探索公众对抗生素治疗 URTIs 的使用经验。然后进行定量综合,探讨公众在使用抗生素治疗 URTIs 方面的行为的流行程度和预测因素。分离的综合相互补充,并进一步整合。
共纳入 86 项研究:48 项定量研究、30 项定性研究、8 项混合方法研究。纳入的研究在欧洲(n=29)、亚洲(n=27)和北美(n=21)进行,评估了患者(n=46)、其父母或照顾者(n=31)或两者(n=9)的行为。出现了 11 个主题,涵盖了 CBM 的六个阶段:需求识别、信息搜索、替代评估、抗生素获取、抗生素使用和使用后评估。六个阶段相互加强,形成一个恶性循环。尽管研究的异质性很高(范围从 0.0 到 92.7%),但公众对抗生素治疗 URTIs 的不合理使用的高流行率是明显的。研究一致认为,对疾病的严重程度的感知和对抗生素的误解是驱动公众不合理使用抗生素治疗 URTIs 的主要动机。然而,减少抗生素使用的个体能力(例如知识)和机会(例如情境限制)的效果是混合的。
需要针对供应和需求两方面进行系统干预。需要教育公众正确管理 URTIs,卫生保健提供者需要通过沟通和处方实践改变公众对抗生素治疗 URTIs 的态度。